Sun Biopharma, Inc.
SEC CIK 1029125 · SNBP · last insider filing 2024-11-19
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Simpson Jennifer K. | Director · President and CEO | filed 2020 - 2024 |
| Jacob Jeffrey E. | Director | filed 2022 - 2023 |
| Mathiesen Jeffrey S | Director | filed 2015 - 2023 |
| Fratamico Arthur | Director | filed 2019 - 2023 |
| Schemel Donald Robert | Director | filed 2015 - 2023 |
| Cullen Michael T. | Director · Executive Chairman | filed 2015 - 2023 |
| Donovan Daniel | Director | filed 2022 - 2023 |
| Gagnon Suzanne | Director · Chief Medical Officer | filed 2015 - 2021 |
| Schaffer Paul W. | Director | filed 2015 - 2021 |
| Kaysen David B | Director · President and CEO | filed 2015 - 2018 |
| Gill Dalvir S | Director | filed 2016 - 2016 |
| Paulson J Robert JR | Director | filed 2015 - 2016 |
| Fuhrman David Michael | Director · President and CEO | filed 2015 - 2015 |
| Sargent Robert John | Director | filed 2015 - 2015 |
| Neenan Thomas X. | Director · Chief Scientific Officer | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Horvath Susan | V.P. of Finance & CFO | filed 2018 - 2024 |
| Kellen Scott | Chief Financial Officer | filed 2015 - 2018 |
| Ryweck Daniel E. | Chief Financial Officer | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.